Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|September 3, 2013
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white womenAparna R Parikh, Celia Patricia Kaplan, Nancy J Burke, et al.
The Oncologist|June 12, 2019
POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan AfricaMadeleine Fish, Jeannette Parkes, Nazima Dharsee, et al.
Bioinformatics Advances|June 24, 2022
fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testingJoshua Millstein, Francesca Battaglin, Hiroyuki Arai, et al.
The Oncologist|May 6, 2022
Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysisAparna R Parikh, Elena Gonzalez-Gugel, Natalia Smolyakova, et al.
Pharmaceutics|December 23, 2023
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular RepairYousef Khazaei Monfared, Pedram Heidari, Samuel J Klempner, et al.
BMC Medical Education|November 12, 2022
Challenges associated with the integration of immuno-oncology agents in clinical practicePatrice Lazure, Aparna R Parikh, Neal E Ready, et al.
Journal of Oncology Practice|January 18, 2017
Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer CareStacy W Gray, Benjamin Kim, Lynette Sholl, et al.
Journal of Oncology Practice|March 11, 2016
Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal CancerAparna R Parikh, Nancy L Keating, Pang-Hsiang Liu, et al.
Cancer Research Communications|August 22, 2022
Methylated Septin9 (m<i>SEPT9</i>): A promising blood-based biomarker for the detection and screening of early-onset colorectal cancerHolli A Loomans-Kropp, Yurong Song, Manish Gala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal CancerAparna R Parikh, Fa-Chyi Lee, Linda Yau, et al.
Pageof 8